Record Information
Version1.0
Creation Date2016-05-25 18:21:28 UTC
Update Date2026-05-14 16:43:14 UTC
Accession NumberCHEM022142
Identification
Common NameDoxazosin
ClassSmall Molecule
DescriptionA member of the class of quinazolines that is quinazoline substituted by an amino group at position 4, methoxy groups at positions 6 and 7 and a piperazin-1-yl group at position 2 which in turn is substituted by a 2,3-dihydro-1,4-benzodioxin-2-ylcarbonyl group at position 4. An antihypertensive agent, it is used in the treatment of high blood pressure.
Contaminant Sources
  • HMDB Contaminants - Urine
  • STOFF IDENT Compounds
Contaminant TypeNot Available
Chemical Structure
Thumb
Synonyms
ValueSource
1-(4-Amino-6,7-dimethoxy-2-chinazolinyl)-4-(2,3-dihydro-1,4-benzodioxixin-2-ylcarbonyl)piperazinChEBI
1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(1,4-benzodioxan-2-ylcarbonyl)piperazinChEBI
DoxazosinaChEBI
DoxazosineChEBI
DoxazosinumChEBI
Cardura XLKegg
Doxazosin mesilateHMDB
Alter brand OF doxazosin mesylateMeSH, HMDB
Apogepha brand OF doxazosin mesylateMeSH, HMDB
AstraZeneca brand OF doxazosin mesylateMeSH, HMDB
CarduraMeSH, HMDB
Ciclum brand OF doxazosin mesylateMeSH, HMDB
combino Brand OF doxazosin mesylateMeSH, HMDB
Doxa purenMeSH, HMDB
DoxacorMeSH, HMDB
Doxazosin alMeSH, HMDB
Doxazosin findusfitMeSH, HMDB
Doxazosina geminisMeSH, HMDB
Geminis brand OF doxazosin mesylateMeSH, HMDB
Gen doxazosinMeSH, HMDB
Heumann brand OF doxazosin mesylateMeSH, HMDB
Juta brand OF doxazosin mesylateMeSH, HMDB
JutalarMeSH, HMDB
Kade brand OF doxazosin mesylateMeSH, HMDB
Linden brand OF doxazosin mesylateMeSH, HMDB
MTW DoxazosinMeSH, HMDB
neo, CarduranMeSH, HMDB
Stadapharm brand OF doxazosinMeSH, HMDB
TAD brand OF doxazosin mesylateMeSH, HMDB
UriductMeSH, HMDB
FindusFit brand OF doxazosin mesylateMeSH, HMDB
ratio-DoxazosinMeSH, HMDB
AlfamedinMeSH, HMDB
Almirall brand OF doxazosin mesylateMeSH, HMDB
Alpharma brand OF doxazosin mesylateMeSH, HMDB
Cantabria brand OF doxazosin mesylateMeSH, HMDB
DiblocinMeSH, HMDB
DoxatensaMeSH, HMDB
Doxazosin mesylateMeSH, HMDB
Doxazosin wolffMeSH, HMDB
Doxazosin ratiopharmMeSH, HMDB
Doxazosin-wolffMeSH, HMDB
Doxazosin-ratiopharmMeSH, HMDB
Doxazosina normonMeSH, HMDB
Doxazosina pharmagenusMeSH, HMDB
Genpharm brand OF doxazosin mesylateMeSH, HMDB
Hexal brand OF doxazosin mesylateMeSH, HMDB
Merck dura brand OF doxazosin mesylateMeSH, HMDB
Monohydrochloride, doxazosinMeSH, HMDB
novo DoxazosinMeSH, HMDB
Progandol neoMeSH, HMDB
Q-Pharm brand OF doxazosin mesylateMeSH, HMDB
ZoxanMeSH, HMDB
CT-Arzneimittel brand OF doxazosin mesylateMeSH, HMDB
Doxazosin von CTMeSH, HMDB
Aliud brand OF doxazosin mesylateMeSH, HMDB
Apotex brand OF doxazosin mesylateMeSH, HMDB
CardularMeSH, HMDB
Carduran neoMeSH, HMDB
Cinfa brand OF doxazosin mesylateMeSH, HMDB
DoxagammaMeSH, HMDB
Doxazosin heumannMeSH, HMDB
Doxazosin monohydrochlorideMeSH, HMDB
Doxazosin betaMeSH, HMDB
Doxazosina combino pharmMeSH, HMDB
Doxazosina ratiopharmMeSH, HMDB
Doxazosina urMeSH, HMDB
Gen-doxazosinMeSH, HMDB
MTW-DoxazosinMeSH, HMDB
Normon brand OF doxazosin mesylateMeSH, HMDB
Ratiopharm brand OF doxazosin mesylateMeSH, HMDB
Solvay brand OF doxazosin mesylateMeSH, HMDB
ratio DoxazosinMeSH, HMDB
1 (4-amino-6,7-Dimethoxy-2-quinazolinyl)-4-((2,3-dihydro-1,4-benzodioxin-2-yl)carbonyl)piperazineMeSH, HMDB
apo DoxazosinMeSH, HMDB
apo-DoxazosinMeSH, HMDB
Azupharma brand OF doxazosin mesylateMeSH, HMDB
CarduranMeSH, HMDB
Doxa-purenMeSH, HMDB
DoxaUroMeSH, HMDB
DoxamaxMeSH, HMDB
DoxazomerckMeSH, HMDB
Doxazosin azuMeSH, HMDB
Doxazosin apogephaMeSH, HMDB
Doxazosin klastMeSH, HMDB
Doxazosin stadaMeSH, HMDB
Doxazosina alterMeSH, HMDB
Doxazosina cinfaMeSH, HMDB
MTW Brand OF doxazosin mesylateMeSH, HMDB
Mesylate, doxazosinMeSH, HMDB
novo-DoxazosinMeSH, HMDB
Novopharm brand OF doxazosin mesylateMeSH, HMDB
Pfizer brand OF doxazosin mesylateMeSH, HMDB
Pharmagenus brand OF doxazosin mesylateMeSH, HMDB
Q Pharm brand OF doxazosin mesylateMeSH, HMDB
Ratiopharm, doxazosinaMeSH, HMDB
Wolff brand OF doxazosin mesylateMeSH, HMDB
Wörwag brand OF doxazosin mesylateMeSH, HMDB
Betapharm brand OF doxazosin mesylateMeSH, HMDB
CT Arzneimittel brand OF doxazosin mesylateMeSH, HMDB
Esparma brand OF doxazosin mesylateMeSH, HMDB
CT, Doxazosin vonMeSH, HMDB
Von CT, doxazosinMeSH, HMDB
Chemical FormulaC23H25N5O5
Average Molecular Mass451.475 g/mol
Monoisotopic Mass451.186 g/mol
CAS Registry Number74191-85-8
IUPAC Name2-[4-(2,3-dihydro-1,4-benzodioxine-2-carbonyl)piperazin-1-yl]-6,7-dimethoxyquinazolin-4-amine
Traditional Namedoxazosin
SMILESCOC1=C(OC)C=C2C(N)=NC(=NC2=C1)N1CCN(CC1)C(=O)C1COC2=CC=CC=C2O1
InChI IdentifierInChI=1S/C23H25N5O5/c1-30-18-11-14-15(12-19(18)31-2)25-23(26-21(14)24)28-9-7-27(8-10-28)22(29)20-13-32-16-5-3-4-6-17(16)33-20/h3-6,11-12,20H,7-10,13H2,1-2H3,(H2,24,25,26)
InChI KeyRUZYUOTYCVRMRZ-UHFFFAOYSA-N
Chemical Taxonomy
Description belongs to the class of organic compounds known as n-arylpiperazines. These are organic compounds containing a piperazine ring where the nitrogen ring atom carries an aryl group.
KingdomOrganic compounds
Super ClassOrganoheterocyclic compounds
ClassDiazinanes
Sub ClassPiperazines
Direct ParentN-arylpiperazines
Alternative Parents
Substituents
  • N-arylpiperazine
  • Quinazolinamine
  • Diazanaphthalene
  • Benzo-1,4-dioxane
  • Benzodioxane
  • Quinazoline
  • Anisole
  • Dialkylarylamine
  • Alkyl aryl ether
  • Aminopyrimidine
  • Para-dioxin
  • Pyrimidine
  • Imidolactam
  • Benzenoid
  • Heteroaromatic compound
  • Tertiary carboxylic acid amide
  • Carboxamide group
  • Amino acid or derivatives
  • Oxacycle
  • Azacycle
  • Carboxylic acid derivative
  • Ether
  • Organic oxygen compound
  • Amine
  • Carbonyl group
  • Organic nitrogen compound
  • Hydrocarbon derivative
  • Organic oxide
  • Organopnictogen compound
  • Organonitrogen compound
  • Organooxygen compound
  • Primary amine
  • Aromatic heteropolycyclic compound
Molecular FrameworkAromatic heteropolycyclic compounds
External Descriptors
Biological Properties
StatusDetected and Not Quantified
OriginNot Available
Cellular LocationsNot Available
Biofluid LocationsNot Available
Tissue LocationsNot Available
PathwaysNot Available
ApplicationsNot Available
Biological RolesNot Available
Chemical RolesNot Available
Physical Properties
StateNot Available
AppearanceNot Available
Experimental Properties
PropertyValue
Melting PointNot Available
Boiling PointNot Available
SolubilityNot Available
Predicted Properties
PropertyValueSource
Water Solubility0.79 g/LALOGPS
logP2.53ALOGPS
logP2.14ChemAxon
logS-2.8ALOGPS
pKa (Strongest Acidic)12.67ChemAxon
pKa (Strongest Basic)7.24ChemAxon
Physiological Charge1ChemAxon
Hydrogen Acceptor Count9ChemAxon
Hydrogen Donor Count1ChemAxon
Polar Surface Area112.27 ŲChemAxon
Rotatable Bond Count4ChemAxon
Refractivity121.64 m³·mol⁻¹ChemAxon
Polarizability46.63 ųChemAxon
Number of Rings5ChemAxon
Bioavailability1ChemAxon
Rule of FiveYesChemAxon
Ghose FilterYesChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Spectra
Spectra
Spectrum TypeDescriptionSplash KeyView
Predicted GC-MSPredicted GC-MS Spectrum - GC-MS (Non-derivatized) - 70eV, Positivesplash10-000i-0792300000-541be6ba12e92be79321Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - GC-MS (Non-derivatized) - 70eV, PositiveNot AvailableSpectrum
Predicted GC-MSPredicted GC-MS Spectrum - GC-MS (Non-derivatized) - 70eV, PositiveNot AvailableSpectrum
LC-MS/MSLC-MS/MS Spectrum - LC-ESI-QFT , negativesplash10-0udi-0010900000-9601aa919c95799ec009Spectrum
LC-MS/MSLC-MS/MS Spectrum - LC-ESI-QFT , negativesplash10-0kei-0981100000-a9ee3121ba6832366f8eSpectrum
LC-MS/MSLC-MS/MS Spectrum - LC-ESI-QFT , negativesplash10-0a4i-0970000000-5261f1bc60ceee4364deSpectrum
LC-MS/MSLC-MS/MS Spectrum - LC-ESI-QFT , negativesplash10-0a4i-0950000000-f649236044e4e2a5de38Spectrum
LC-MS/MSLC-MS/MS Spectrum - LC-ESI-QFT , negativesplash10-0a4i-1920000000-86655cc3bb892d757068Spectrum
LC-MS/MSLC-MS/MS Spectrum - LC-ESI-QFT , negativesplash10-0a4i-1900000000-88bca2ddf2930fa0c468Spectrum
LC-MS/MSLC-MS/MS Spectrum - LC-ESI-QFT , positivesplash10-0udi-0000900000-449254642300c1324285Spectrum
LC-MS/MSLC-MS/MS Spectrum - LC-ESI-QFT , positivesplash10-0udi-0002900000-3097c8a3403b52610918Spectrum
LC-MS/MSLC-MS/MS Spectrum - LC-ESI-QFT , positivesplash10-0006-0079100000-06d36a9b7afe6cf0c6e9Spectrum
LC-MS/MSLC-MS/MS Spectrum - LC-ESI-QFT , positivesplash10-000t-1091000000-cbd9b2106818ef5fd2baSpectrum
LC-MS/MSLC-MS/MS Spectrum - LC-ESI-QFT , positivesplash10-001i-1190000000-a1c84b0c3657d8000e35Spectrum
LC-MS/MSLC-MS/MS Spectrum - LC-ESI-QFT , positivesplash10-001i-1390000000-e802cb93ca8d6934ee96Spectrum
LC-MS/MSLC-MS/MS Spectrum - 30V, Positivesplash10-0udi-0002900000-4bf3463746e5cedb4582Spectrum
LC-MS/MSLC-MS/MS Spectrum - 15V, Positivesplash10-0udi-0000900000-439134f282b4b9ac6da0Spectrum
LC-MS/MSLC-MS/MS Spectrum - 45V, Positivesplash10-0006-0079100000-e52fef19f2d7df13686fSpectrum
LC-MS/MSLC-MS/MS Spectrum - 60V, Positivesplash10-000t-1091000000-8545cbf9afb97ce44d20Spectrum
LC-MS/MSLC-MS/MS Spectrum - 60V, Negativesplash10-0a4i-0950000000-1a542e27420bd69823afSpectrum
LC-MS/MSLC-MS/MS Spectrum - 45V, Negativesplash10-0a4i-0970000000-7ca89cc9e15bcae386a0Spectrum
LC-MS/MSLC-MS/MS Spectrum - 15V, Negativesplash10-0udi-0010900000-6e481ed6a67e73c1a9e4Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 10V, Positivesplash10-0udi-1020900000-64c5e9c37f904260cdbdSpectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 20V, Positivesplash10-0f6x-1387900000-1564571c4e6f2bd22799Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 40V, Positivesplash10-0032-5090000000-29e9f7a134a59719b1e7Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 10V, Negativesplash10-0udi-0213900000-03663ba73cebf8b1bbb7Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 20V, Negativesplash10-0h3i-0494500000-e01cd92097617b53aceaSpectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 40V, Negativesplash10-059f-4193000000-4a19be62579d7f700895Spectrum
Toxicity Profile
Route of ExposureNot Available
Mechanism of ToxicityNot Available
MetabolismNot Available
Toxicity ValuesNot Available
Lethal DoseNot Available
Carcinogenicity (IARC Classification)Not Available
Uses/SourcesNot Available
Minimum Risk LevelNot Available
Health EffectsNot Available
SymptomsNot Available
TreatmentNot Available
Concentrations
Not Available
DrugBank IDDB00590
HMDB IDHMDB0257073
FooDB IDNot Available
Phenol Explorer IDNot Available
KNApSAcK IDNot Available
BiGG IDNot Available
BioCyc IDNot Available
METLIN IDNot Available
PDB IDNot Available
Wikipedia LinkDoxazosin
Chemspider ID3045
ChEBI ID4708
PubChem Compound IDNot Available
Kegg Compound IDC06970
YMDB IDNot Available
ECMDB IDNot Available
References
Synthesis ReferenceNot Available
MSDSNot Available
General References
1. https://www.ncbi.nlm.nih.gov/pubmed/?term=17171413
2. https://www.ncbi.nlm.nih.gov/pubmed/?term=18559700